Abstract
Conclusion: Vertigo treatment and rehabilitation chair (TRV) may be suggested as the first choice for patients with posterior canal benign paroxysmal positional vertigo (p-BPPV). Objective: To investigate the short- and long-term treatment efficacy of the canalith repositioning procedure (CRP) versus TRV for patients with p-BPPV. Methods: A total of 165 patients with unilateral p-BPPV were assigned to either the CRP group or the TRV group. Patients were assessed at 1 week, 4 weeks, 3 months, and 6 months after their first treatment. The numbers of treatment sessions required for successful repositioning in both groups at 4 weeks, 3 months, and 6 months were recorded. Results: Treatment efficacy of patients in the TRV group was significantly better than that of patients in the CRP group 1 week after the first treatment. The number of treatment sessions needed for successful repositioning was significantly lower in the TRV group than in the CRP group at 4 weeks and 3 months after the first treatment.
Keywords::
Acknowledgments
This work was supported by Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period from the National Health and Family Planning Commission of China (no. 2012BAI12B00/2012BAI12B01) and a grant from Shanghai Municipal Commission of Health and Family Planning (no. 2013SY040).
Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.